Today’s recruitment shortages and access to remote research sites pose a challenge in rare disease research — but Cerba means certainty. Together, we can shape and advance your complex trial by leveraging Cerba HealthCare patient databases and biorepositories spanning five continents. AI-driven access to demographically rich data and industry-leading laboratories save you time and effort, enabling your project to move forward.

Patients screened 28,496 Patients screened
Sites 4,865 Sites
Countries 62 Countries


of our pediatric trials focus on rare diseases


of trials in rare diseases are multiple myeloma trials


of trials in rare diseases are leukemia trials

Acute myeloid leukemia
Acute lymphoblastic leukemia
Chronic lymphocytic leukemia

Enhance your research with patient- and data-driven insights

We offer a broad continuum of services and capabilities for research into rare diseases, particularly cancers. Get the help you need with: